Progress and controversy in the treatment of childhood rhabdomyosarcoma.
D000293:Adolescent; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009362:Neoplasm Metastasis; D009367:Neoplasm Staging; D011183:Postoperative Complications / Q000209:etiology; D011379:Prognosis; D011832:Radiation Injuries / Q000209:etiology; D012075:Remission, Spontaneous; D012208:Rhabdomyosarcoma / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D012983:Soft Tissue Neoplasms / Q000209:etiology / Q000473:pathology / Q000628:therapy*; D013997:Time Factors
D000970:Antineoplastic Agents